Cite Filings / CGEM / 0000950170-23-021253
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
10-Q

Quarterly Report

Cullinan Therapeutics, Inc. · Filed 2023-05-11 · Acc 0000950170-23-021253

Documents 1

  • 10-Q Quarterly Report , cgem-20230331.htm

Around this filing

  • 2023-08-10 10-Q Quarterly Report
  • 2023-05-16 4 Chief Development Officer sold 193 shares at $8.78 ($1,695)
  • 2023-05-16 4 Chief Financial Officer sold 347 shares at $8.78 ($3,047)
  • 2023-05-11 S-3/A Registration Statement
  • 2023-05-11 8-K Results of operations
  • 2023-05-11 10-Q Quarterly Report
  • 2022-11-14 10-Q Quarterly Report

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
  • SEC Structured Data (opens in new tab)
Loading cgem-20230331.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…